Biotech Acquisition Cormpany (NASDAQ:BIOT) has postponed its special meeting to complete its combination with pharmaceutical firm Blade Therapeutics from June 1 to 10 am ET, June 3.
The SPAC has obtained sufficient votes to approve the transaction but needs additional time to satisfy all closing conditions, according to Biotech’s press release. The record date for the vote remains unchanged as March 28.
There is a minimum closing condition of $75 million for this deal and had originally announced a PIPE of $24.3 million anchored by leading institutional investors, including Deerfield Management, Pfizer Ventures, Bristol Myers Squibb, MPM Capital and Osage University Partners.
Biotech, which raised $230 million at IPO, initially announced its $352.8 million deal with Blade Therapeutics on November 8. San Francisco-based Blade Therapeutics is developing three drug candidates as potential therapies against varying forms of organ fibrosis with its most advanced having completed Phase I.
April highlighted two defining trends in the SPAC market: an increased reliance on extended deadlines and a surge in announced transactions. Extension votes doubled compared to March, while the number of De-SPAC deals disclosed reached nine in April alone. These developments underscore a market that remains active but continues to rely on deadline extensions, largely...
D. Boral ARC Acquisition Corp. I has filed for a $250 million SPAC to be David Boral’s first in-house SPAC since the internal split at the firm formerly known as EF Hutton. Before that split, Boral and his former partner Joseph Rallo served as executive managers for the EF Hutton I SPAC, which ultimately combined...
At the SPAC of Dawn SPAC activity has continued on hot and heavy as three more new SPACs have filed S-1s for IPOs – one from each of the year’s most prolific underwriters: Cantor Fitzgerald, BTIG and Cohen & Company. Two more SPACs have are also set to join the party today having priced their...
Republic Digital Acquisition Corp. (NASDAQ:RDAGU) announced the pricing of its upsized $264 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “RDAGU”, Thursday, May 1, 2025. The new SPAC aims to combine with a target company in the fintech, software or cryptocurrency industries with substantial free cash flow....
Copley Acquisition Corp. (NYSE:COPL.U) announced the pricing of its $150 million IPO and its units are expected to begin trading on the NYSE under the symbol “COPL.U”, Thursday, May 1, 2025. The new SPAC aims to combine with a company in the technology or lifestyle sectors that have the ability to scale and enhance growth....